AUS
NZ
UK
CA
USA
IND
Cannabis
Little Green Pharma (ASX:LGP): The Cannabis Reality Check Reshaping Sector
June 19, 2026 03:08 PM AEST| By SamAustralia's cannabis sector is shifting from speculation to execution, with revenue, compliance and commercial performance emerging as the key factors separating established operators from businesses still pursuing market traction.
Why Little Green Pharma (ASX:LGP) Is Riding a Growing Trend
June 19, 2026 03:03 PM AEST| By SamAustralia's medical cannabis sector is evolving into a significant healthcare market, supported by growing patient adoption, increasing clinical acceptance and expanding commercial opportunities for established industry participants.
Why This ASX Cannabis Story Is Drawing Fresh Attention
June 19, 2026 12:55 PM AEST| By SamASX cannabis stocks are facing greater scrutiny as patient access, prescription quality and regulatory discipline become central themes. Companies are increasingly evaluated on evidence, execution and sustainable operational performance.
Is Tetragon Energy Worth Watching Ahead of Its $4M Oil and Gas Exploration IPO?
June 21, 2026 03:12 AM AEST| By Sonal Goyal
Why Export Quality Is Reshaping ASX Cannabis Stocks
June 19, 2026 12:55 PM AEST| By Team Kalkine MediaAustralian cannabis companies are increasingly judged on export quality, compliance standards and commercial execution as European demand and operational discipline become key themes across the sector.
The Cannabis Metric Quietly Reshaping ASX 200 Watchlists
June 19, 2026 12:55 PM AEST| By SamASX cannabis stocks are increasingly being judged on cash runway, cost control and commercial scale as investors focus on financial resilience and sustainable business execution.
Australia's Cannabis Market Is Booming - Can ASX Stocks Cash In?
June 18, 2026 04:00 PM AEST| By SamAustralia’s medicinal cannabis industry continues to expand through growing patient demand, telehealth adoption and broader treatment options, while regulatory hurdles, funding needs and international competition remain important challenges.
Ora Banda Mining (ASX:OBM) Lays Out Multi-Year Expansion Strategy and Capital Projects
June 21, 2026 01:43 AM AEST| By Sonal GoyalOra Banda Mining (ASX:OBM) has introduced itsDRIVE to 300 initiative, a three-year development strategy designed to significantly increase production capacity and operational scale.
Vitura Health Drives ASX Cannabis Stock Consolidation Through Telehealth
June 18, 2026 03:45 PM AEST| By SamVitura Health is strengthening its position in Australia's medicinal cannabis sector through telehealth expansion, integrated healthcare services and strategic acquisitions, highlighting the growing consolidation trend shaping the industry's next sta...
Why Cash Runway Matters More Than Ever for ASX Cannabis Stocks
June 18, 2026 10:39 AM AEST| By SamAustralia's cannabis sector is evolving as investors place greater emphasis on cash runway, commercial execution and sustainable growth, shifting attention away from expansion narratives and towards long-term business performance.
Medicinal Cannabis Shares Meet A Stricter Export Check
June 18, 2026 10:39 AM AEST| By SamCannabis stocks face a sharper export quality test as medicinal access, product standards, revenue durability and funding discipline become central to the latest ASX sector story.
Is Lux Copper Corp Worth Watching Ahead of Its $15M Copper Exploration IPO?
June 21, 2026 01:40 AM AEST| By Sonal Goyal
ASX 200 Cannabis Stocks Face A Revenue Test
June 18, 2026 10:39 AM AEST| By SamCannabis stocks remain under review as regulated access, medicinal demand, export revenue and capital discipline shape whether ASX operators can close the gap between sector interest and commercial scale.
ASX Cannabis Stocks: Why the Medicinal Access Filter Matters
June 17, 2026 03:04 PM AEST| By SamAustralia's medicinal cannabis sector is drawing renewed attention as markets focus on patient access, regulatory pathways and commercial execution. Companies with stronger revenue visibility, financial discipline and healthcare integration are becom...
ASX Cannabis Stocks: Cash Runway Reality Takes Centre Stage
June 17, 2026 02:54 PM AEST| By SamAustralian cannabis stocks are back in focus as investors assess cash runway, manufacturing scale, balance-sheet strength and operational execution. Companies with sustainable growth pathways are attracting the greatest market attention.
Up 375% in 5-years: Why Sigma Healthcare (ASX:SIG) facing pressure recently?
June 21, 2026 01:13 AM AEST| By Sonal GoyalHighlightsSigma Healthcare Limited (ASX: SIG) shares were trading at AUD 2.76, down 1.78% or AUD 0.050, as of 4:10 pm on 19 June 2026.For the half year ended 31 December 2025 (1H26), normalised EBIT rose 18.7% to $582.9 million and normalised NPAT rose 19.2% …
ASX 200 Cannabis Stocks Shift Toward Clinical Proof
June 17, 2026 11:07 AM AEST| By SamASX 200 cannabis stocks are increasingly shaped by clinical evidence as research-backed cannabinoid therapies support medical adoption, regulatory acceptance and global expansion across structured healthcare markets.
ASX Cannabis Stocks Face Reality Check in 2026
June 17, 2026 11:06 AM AEST| By SamASX cannabis stocks are entering a more mature phase where revenue, compliance and execution now define success, with Little Green Pharma and Cann Group reflecting the industry’s evolving commercial focus.
Cannabis Merger Shock Reshapes ASX Growth Story
June 17, 2026 11:06 AM AEST| By SamLittle Green Pharma’s merger with Cannatrek highlights growing consolidation in the Australian medicinal cannabis sector, with emphasis on manufacturing scale, regulated compliance and expanding European export opportunities.
Can Neu Horizon Uranium Capitalise on Renewed Nuclear Demand? Here Is What to Know Before Listing
June 21, 2026 12:12 AM AEST| By Sonal Goyal
ASX Cannabis Exports Drive Growth in Global Markets
June 17, 2026 04:21 AM AEST| By SamASX cannabis companies are expanding into Europe, with export-led growth reshaping sector structure and strengthening international supply chain integration.
Cash Runway Takes Centre Stage for ASX Cannabis Stocks
June 16, 2026 03:00 PM AEST| By SamASX cannabis stocks are entering a more disciplined phase as investors focus on funding strength, operational execution and sustainable commercial growth.
Export Standards or Scale? The New Challenge Facing Cannabis Stocks
June 16, 2026 03:00 PM AEST| By SamASX cannabis stocks are increasingly being assessed on export readiness, operational execution and commercial scale as the medicinal cannabis sector continues to mature.
Daly Resources IPO: Should This Northern Territory Exploration Float Be on Your ASX Watchlist?
June 20, 2026 11:10 PM AEST| By Sonal Goyal
Regulatory Reality: Why Cannabis Stocks Are Back on Investors’ Watchlists
June 16, 2026 03:00 PM AEST| By SamASX cannabis stocks are being increasingly assessed through patient access, regulatory compliance, distribution strength and commercial execution as investors become more selective.
Little Green Pharma (ASX:LGP) Bulks Up as Cannatrek Merger Completes
June 16, 2026 11:35 AM AEST| By SamLittle Green Pharma completes its Cannatrek merger, strengthening vertical integration and scale as the ASX cannabis sector continues consolidating toward revenue-focused, regulated and operationally disciplined businesses.
Advertise your brand on Kalkine Media